Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder
NCT ID: NCT00931775
Last Updated: 2009-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
30 participants
INTERVENTIONAL
2002-12-31
2005-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
NCT01312922
Citalopram vs Clomipramine vs Placebo in Recurrent Depression
NCT01575158
Can Additional Drug Therapy Accelerate Response Time to Antidepressants
NCT00221494
Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation
NCT02113943
Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
NCT01557946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Citalopram + placebo
Citalopram 20 mg/day t.i.d
Pindolol
Pill orally administered. 15 mg/day t.i.d.
Citalopram + pindolol
Citalopram 20 mg/day t.i.d Pindolol 15 mg/day t.i.d.
Pindolol
Pill orally administered. 15 mg/day t.i.d.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pindolol
Pill orally administered. 15 mg/day t.i.d.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HDRS score \> 18
* Written informed consent
Exclusion Criteria
* severe organic illness
* other psychotropic drugs
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital de la Santa Creu i Sant Pau. Psychiatry Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enric Álvarez, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Psychiatry. Hospital de la Santa Creu i Sant Pau
Víctor Pérez, MD, PhD
Role: STUDY_DIRECTOR
Department of Psychiatry. Hospital de la Santa Creu i Sant Pau
Francesc Artigas, PhD
Role: STUDY_CHAIR
Neurochemistry department. Consejo Superior de Investigaciones Científicas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Outpatients Service of Psychiatry Department. Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Portella MJ, de Diego-Adelino J, Ballesteros J, Puigdemont D, Oller S, Santos B, Alvarez E, Artigas F, Perez V. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. J Clin Psychiatry. 2011 Jul;72(7):962-9. doi: 10.4088/JCP.09m05827blu. Epub 2010 Oct 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIT-PIN_01-0C3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.